Home › Stock analysis › LH
Labcorp (LH) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
LH rises 2.4% to $325.07, a 1-month high. Closed at $325.07, +2.44% vs the prior close of $317.34. Day range $320.22–$325.15, opened at $321.60.
Last close$325.07+2.44%
Day range320.22–325.15
Open321.60
Volume542.00K
52-week range244.52–341.80
Avg volume (20d)768.05K
LH daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — LH rises 2.4% to $325.07, a 1-month high
- Closed at $325.07, +2.44% vs the prior close of $317.34. Day range $320.22–$325.15, opened at $321.60.
- Volume was 542.00K shares, 0.8x its 50-day average of 683.79K.
- Price is +1.5% vs its 50-day average ($320.40) and +14.8% vs its 200-day average ($283.06).
- 52-week range $244.52–$341.80; today's close sits at 83% of that range, 4.9% below the 52-week high.
Oct 14, 2026 — LH rises 1.2% to $317.34
- Closed at $317.34, +1.18% vs the prior close of $313.64. Day range $314.10–$319.75, opened at $314.10.
- Volume was 573.60K shares, 0.8x its 50-day average of 687.28K.
- Price is -0.9% vs its 50-day average ($320.18) and +12.3% vs its 200-day average ($282.70).
- 52-week range $244.52–$341.80; today's close sits at 75% of that range, 7.2% below the 52-week high.
Oct 13, 2026 — LH dips 0.6% to $313.64
- Closed at $313.64, -0.60% vs the prior close of $315.52. Day range $312.22–$319.30, opened at $316.70.
- Volume was 453.80K shares, 0.7x its 50-day average of 692.75K.
- Price is -2.0% vs its 50-day average ($320.08) and +11.1% vs its 200-day average ($282.38).
- 52-week range $244.52–$341.80; today's close sits at 71% of that range, 8.2% below the 52-week high.
Oct 12, 2026 — LH rises 1.1% to $315.52
- Closed at $315.52, +1.08% vs the prior close of $312.15. Day range $310.11–$316.75, opened at $310.11.
- Volume was 405.30K shares, 0.6x its 50-day average of 706.46K — lighter than usual.
- Price is -1.4% vs its 50-day average ($319.95) and +11.9% vs its 200-day average ($282.09).
- 52-week range $244.52–$341.80; today's close sits at 73% of that range, 7.7% below the 52-week high.
Oct 9, 2026 — LH dips 0.7% to $312.15
- Closed at $312.15, -0.65% vs the prior close of $314.20. Day range $311.62–$318.18, opened at $313.39.
- Volume was 607.90K shares, 0.8x its 50-day average of 722.28K.
- Price is -2.4% vs its 50-day average ($319.83) and +10.8% vs its 200-day average ($281.78).
- 52-week range $244.52–$341.80; today's close sits at 70% of that range, 8.7% below the 52-week high.
Oct 8, 2026 — LH rises 0.7% to $314.20, 5 up days in a row
- Closed at $314.20, +0.71% vs the prior close of $311.97. Day range $309.04–$315.48, opened at $312.34.
- Volume was 703.70K shares, 1.0x its 50-day average of 732.07K.
- Price is -1.8% vs its 50-day average ($319.90) and +11.6% vs its 200-day average ($281.49).
- 52-week range $244.52–$341.80; today's close sits at 72% of that range, 8.1% below the 52-week high.
- That makes 5 straight gains.
Oct 7, 2026 — LH ends flat (+0.1%) to $311.97, 4 up days in a row
- Closed at $311.97, +0.08% vs the prior close of $311.71. Day range $311.21–$315.09, opened at $312.04.
- Volume was 546.60K shares, 0.7x its 50-day average of 743.86K.
- Price is -2.4% vs its 50-day average ($319.76) and +11.0% vs its 200-day average ($281.18).
- 52-week range $244.52–$341.80; today's close sits at 69% of that range, 8.7% below the 52-week high.
- That makes 4 straight gains.
Oct 6, 2026 — LH rises 1.0% to $311.71, 3 up days in a row
- Closed at $311.71, +0.99% vs the prior close of $308.65. Day range $304.92–$312.76, opened at $310.41.
- Volume was 987.80K shares, 1.3x its 50-day average of 737.21K.
- Price is -2.5% vs its 50-day average ($319.80) and +11.0% vs its 200-day average ($280.88).
- 52-week range $244.52–$341.80; today's close sits at 69% of that range, 8.8% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — LH ends flat (+0.1%) to $308.65
- Closed at $308.65, +0.05% vs the prior close of $308.49. Day range $305.84–$309.79, opened at $308.08.
- Volume was 705.90K shares, 1.0x its 50-day average of 741.42K.
- Price is -3.4% vs its 50-day average ($319.59) and +10.0% vs its 200-day average ($280.60).
- 52-week range $244.52–$341.80; today's close sits at 66% of that range, 9.7% below the 52-week high.
Oct 2, 2026 — LH rises 1.3% to $308.49
- Closed at $308.49, +1.28% vs the prior close of $304.60. Day range $302.71–$309.36, opened at $305.77.
- Volume was 588.20K shares, 0.8x its 50-day average of 759.78K.
- Price is -3.4% vs its 50-day average ($319.35) and +10.0% vs its 200-day average ($280.35).
- 52-week range $244.52–$341.80; today's close sits at 66% of that range, 9.7% below the 52-week high.
Things to know before you trade LH
- Last results release: Jul 30, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Feb 17, 2026, Oct 28, 2025. Based on that rhythm, the next report is likely around Oct 29, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.93% (largest 2.9%). That is a relatively calm stock.
- Liquidity: about 768.05K shares (≈$249.67M) trade per day on average.
- 52-week position: $325.07 vs a range of $244.52–$341.80 (83% of the range).
- Dividends: last ex-dividend date Aug 28, 2026 ($0.72/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 21 sales; latest: Kerrii B Anderson sold 3,000 shares on Aug 17, 2026.
- Latest filings: 8-K Sep 30, 2026; 8-K Sep 22, 2026; 8-K Sep 10, 2026.
- Share count: 81.10M shares outstanding (Aug 4, 2026), -2.4% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Services-Medical Laboratories.
LH market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 321.60 | 325.15 | 320.22 | 325.07 | 542.00K |
| Oct 14, 2026 | 314.10 | 319.75 | 314.10 | 317.34 | 573.60K |
| Oct 13, 2026 | 316.70 | 319.30 | 312.22 | 313.64 | 453.80K |
| Oct 12, 2026 | 310.11 | 316.75 | 310.11 | 315.52 | 405.30K |
| Oct 9, 2026 | 313.39 | 318.18 | 311.62 | 312.15 | 607.90K |
| Oct 8, 2026 | 312.34 | 315.48 | 309.04 | 314.20 | 703.70K |
| Oct 7, 2026 | 312.04 | 315.09 | 311.21 | 311.97 | 546.60K |
| Oct 6, 2026 | 310.41 | 312.76 | 304.92 | 311.71 | 987.80K |
| Oct 5, 2026 | 308.08 | 309.79 | 305.84 | 308.65 | 705.90K |
| Oct 2, 2026 | 305.77 | 309.36 | 302.71 | 308.49 | 588.20K |
| Oct 1, 2026 | 306.00 | 309.72 | 304.06 | 304.60 | 559.40K |
| Sep 30, 2026 | 311.00 | 311.54 | 306.98 | 308.11 | 646.20K |
| Sep 29, 2026 | 306.89 | 309.95 | 306.58 | 308.81 | 613.10K |
| Sep 28, 2026 | 306.85 | 312.57 | 306.85 | 309.57 | 774.50K |
| Sep 25, 2026 | 308.24 | 312.30 | 306.55 | 309.64 | 821.50K |
| Sep 24, 2026 | 304.62 | 309.54 | 303.13 | 308.95 | 784.90K |
| Sep 23, 2026 | 311.91 | 312.82 | 303.50 | 303.98 | 909.20K |
| Sep 22, 2026 | 303.46 | 316.53 | 303.46 | 311.54 | 1.91M |
| Sep 21, 2026 | 321.95 | 323.84 | 318.94 | 320.99 | 487.40K |
| Sep 18, 2026 | 322.00 | 322.70 | 319.38 | 320.71 | 1.74M |
About Labcorp
Labcorp (LH) is listed on the NYSE and classified by the SEC under “Services-Medical Laboratories”. Its business address is in BURLINGTON, NC. Fiscal year ends December 31. SEC CIK 920148.
LH board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Kerrii B Anderson | Director | Aug 18, 2026 |
| Carulla Victor Bulto | Director | Feb 12, 2026 |
| Jeffrey A. Davis | Director | Feb 13, 2026 |
| Kirsten Marie Kliphouse | Director | Feb 13, 2026 |
| Garheng Kong | Director | Feb 13, 2026 |
| Peter M Neupert | Director | Feb 13, 2026 |
| Richelle P Parham | Director | Feb 13, 2026 |
| Paul Rothman | Director | Feb 13, 2026 |
| John H Sampson | Director | Feb 12, 2026 |
| Adam H Schechter | President & CEO | Aug 12, 2026 |
| Kathryn E Wengel | Director | Feb 13, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Megan D. Bailey | EVP, Pres, Central Labs & Intl | Mar 30, 2026 |
| Brian J Caveney | EVP, Pres of BLS, CMO & CSO | Sep 3, 2026 |
| Anita Z Graham | EVP, CHRO | Mar 30, 2026 |
| Kathryn W Kyle | EVP, Chief Legal Officer | Jul 6, 2026 |
| Jonathan C Meltzer | EVP, COO | Sep 3, 2026 |
| Akinbolade Oyegunwa | EVP, CIO & CTO | Sep 3, 2026 |
| Adam H Schechter | President & CEO | Aug 12, 2026 |
| Mark S Schroeder | EVP, Pres Diagnostics & COO | Mar 30, 2026 |
| Amy B. Summy | EVP, Chief Marketing Officer | Aug 6, 2026 |
| Bryan T Vaughn | EVP and President, Diagnostics | Sep 3, 2026 |
| Julia Aijun Wang | Chief Financial Officer, EVP | Feb 13, 2026 |
| Peter J Wilkinson | SVP, Chief Accounting Officer | Aug 5, 2026 |
| Der Vaart Sandra D Van | EVP, Corporate Affairs | Mar 30, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 17, 2026 | Kerrii B Anderson | Sale | 3,000 | $318.02 |
| Aug 11, 2026 | Adam H Schechter | Sale | 4,669 | $320.37 |
| Aug 4, 2026 | Amy B. Summy | Sale | 924 | $306.74 |
| Aug 3, 2026 | Peter J Wilkinson | Sale | 1,338 | $309.23 |
| Aug 3, 2026 | Peter J Wilkinson | Sale | 82 | $309.22 |
| Jul 2, 2026 | Bryan T Vaughn | Sale | 234 | $286.19 |
| Jul 2, 2026 | Kathryn W Kyle | Sale | 92 | $286.19 |
| Jun 8, 2026 | Kathryn W Kyle | Sale | 762 | $263.89 |
| May 11, 2026 | Adam H Schechter | Sale | 5,903 | $254.50 |
| Mar 27, 2026 | Peter J Wilkinson | Sale | 1,633 | $267.05 |
| Mar 27, 2026 | Jonathan C Meltzer | Sale | 839 | $267.05 |
| Mar 3, 2026 | Adam H Schechter | Sale | 8,705 | $279.96 |
| Feb 27, 2026 | Der Vaart Sandra D Van | Sale | 548 | $284.91 |
| Feb 24, 2026 | Brian J Caveney | Sale | 1,500 | $286.31 |
| Feb 19, 2026 | Peter J Wilkinson | Sale | 666 | $277.94 |
LH financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $13.95B | $876.50M | 10.46 | $1.64B |
| Dec 31, 2024 | $13.01B | $746.00M | 8.84 | $1.59B |
| Dec 31, 2023 | $12.16B | $418.00M | 4.77 | $1.33B |
| Dec 31, 2022 | $11.86B | $1.28B | 13.97 | $1.96B |
| Dec 31, 2021 | $13.14B | $2.38B | 24.39 | $3.11B |
Latest balance sheet: total assets $18.53B, total liabilities $9.91B, cash $141.80M (as of Jun 30, 2026).
LH earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 30, 2026 | 8-K Item 2.02 (results) | $315.53 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $256.80 |
| Feb 17, 2026 | 8-K Item 2.02 (results) | $276.67 |
| Oct 28, 2025 | 8-K Item 2.02 (results) | $259.69 |
| Jul 24, 2025 | 8-K Item 2.02 (results) | $267.69 |
| Apr 29, 2025 | 8-K Item 2.02 (results) | $240.42 |
| Feb 6, 2025 | 8-K Item 2.02 (results) | $247.74 |
| Oct 24, 2024 | 8-K Item 2.02 (results) | $230.07 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| Apr 25, 2024 | 8-K Item 2.02 (results) | — |
| Feb 15, 2024 | 8-K Item 2.02 (results) | — |
| Oct 26, 2023 | 8-K Item 2.02 (results) | — |
More on LH
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.